Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary Tuberculosis

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 435 participants.

Also called NCT02169570

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 435 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02169570
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Pakistan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02169570. Randomized; triple masking; primary purpose treatment. Start 2014-12 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary Tuberculosis
Acronym
EVIDENT
Condition
Type 2 Diabetes Mellitus
Condition
Pulmonary Tuberculosis
Intervention (Dietary supplement)
Vitamin D
Intervention (Dietary supplement)
Calcium
Intervention (Dietary supplement)
Placebo Vit D
Intervention (Dietary supplement)
Placebo Calcium
Lead sponsor
Dow University of Health Sciences (class: other)

Record details

Record id
cardio:ct-nct02169570
Content hash
1d49241b17e916a4329d07f1578abc27f970626d116de70edf3f20baebd1fe5c